Mubadala Capital Ventures
North America, California, United States, San Francisco
Description
Mubadala Ventures is the venture capital arm of Mubadala that focuses on advanced technology.
Investor Profile
Mubadala Capital Ventures has made 121 investments, with 5 in the past 12 months and 24% as lead.
Stage Focus
- Series A (26%)
- Series B (23%)
- Series C (12%)
- Seed (8%)
- Series D (8%)
- Post Ipo Equity (7%)
- Series Unknown (7%)
- Series E (5%)
- Private Equity (3%)
- Series F (1%)
Country Focus
- United States (72%)
- Germany (6%)
- United Kingdom (5%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- China (3%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- Sweden (2%)
- Austria (2%)
- France (2%)
- United Arab Emirates (2%)
- Russian Federation (2%)
- Switzerland (1%)
Industry Focus
- Health Care
- Biotechnology
- Software
- Therapeutics
- Artificial Intelligence (Ai)
- Information Technology
- Medical
- Life Science
- Pharmaceutical
- Financial Services
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
